The biotech sector is witnessing increased merger and acquisition interest from major pharmaceutical companies, particularly in the oncology space. This trend could reshape the competitive landscape for several smaller firms.
- Potential oncology M&A activity
- Speculation on biotech acquisitions
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.
Share this article